David O. Watson
CIK 1657719 · General Counsel · last filed 2026-05-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
59
Lifetime Open-Market Net
-$6.80M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. (APLS) Delisted | General Counsel | 0 | $41.03 | $0 | -$6.80M | 59 | 2026-05-14 |
Recent Filings · Page 3 of 6
59 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-12-13 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −5,000 | -$171.2K | EDGAR |
| 2024-09-30 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Gift (G) | — | $0 | EDGAR |
| 2024-03-08 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Exer (M) | +3,762 | $52.1K | EDGAR |
| 2024-02-13 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −781 | -$52.9K | EDGAR |
| 2024-01-31 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −906 | -$58.1K | EDGAR |
| 2024-01-23 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −4,184 | -$271.9K | EDGAR |
| 2024-01-17 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | +19,508 | -$283.3K | EDGAR |
| 2023-12-20 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | +4,000 | -$114.0K | EDGAR |
| 2023-07-06 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −8,510 | -$765.7K | EDGAR |
| 2023-06-29 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Gift (G) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.